有晶状体眼人工晶状体植入术后二次手术临床分析
Clinical analysis of secondary surgery after phakic implantable collamer lens implantation
目的 探讨有晶状体眼人工晶状体 (ICL) 植入术后二次手术的临床特点、有效性和安全性。方法 选取沈阳何氏眼科医院有限公司2022年4月至2024年3月间接受ICL或散光型有晶状体眼人工晶状体 (TICL) 植入术后二次手术的屈光不正患者35例 (37眼),二次手术间隔时间为1~186 d,平均 (77.25±67.19) d。将因拱高异常行二次手术患者分为高拱高组 (17例、18眼) 和低拱高组 (14例、15眼),以同期单纯ICL/TICL植入术患者 (30例、30眼) 作为对照组,比较各组患者首次术前等效球镜 (SE)、角膜水平径 (hWTW)、睫状沟水平径 (hSTS)、前房深度 (ACD)、前房容积 (ACV)、前房角 (ACA)、晶状体厚度 (LT) 等眼前节参数的差异。通过评估二次术后裸眼视力 (UCVA)、SE、眼压 (IOP)、 角膜内皮细胞密度 (ECD)及并发症发生情况分析二次手术的有效性和安全性。结果 二次手术患者35例 (37眼) 中,需调位18眼,更换19眼 (ICL调位14眼,置换14眼; TICL调位4 眼,置换5眼),TICL调位的4眼中有3眼为术后散光残留,1眼为术后眼外伤造成人工晶状体攀移入前房。高拱高组、低拱高组 (首次术前) 与对照组术前SE、ACA、hWTW、睫状沟垂直径 (vSTS)、眼轴长度 (AL)比较差异均无统计学意义 (P > 0.05),而ACD、ACV、hSTS、hWTW-hSTS、LT比较差异有统计学意义 (P < 0.05)。 组间比较结果显示,低拱高组ACD、ACV显著低于高拱高组与对照组 (P < 0.05),而LT显著高于高拱高组与对照组 (P < 0.05); 低拱高组hSTS显著低于对照组,hWTW-hSTS显著高于对照组 (P < 0.05)。TICL患者因人工晶状体旋转造成散光残留,经调位术后1个月散光为-0.75 D±0.25 D,术后UCVA LogMAR由0.18±0.15提高到-0.13±0.05,手术前后散光、UCVA比较差异有统计学意义 (P < 0.001)。与对照组比较,二次手术患者术后1个月UCVA、SE、IOP、ECD水平差异无统计学意义 (P > 0.05)。结论 拱高异常和散光残留是有晶状体眼ICL植入术后二次手术的主要原因。二次手术具有良好的安全性和有效性,ICL尺寸的选择仍有进一步优化空间。
Objective To investigate the clinical characteristics,efficacy,and safety of secondary surgery following phakic implantable collamer lens (ICL) implantation. Methods This study enrolled 35 patients (37 eyes) with refractive errors who underwent secondary surgery after ICL or toric phakic ICL (TICL) implantation at Shenyang He’s Eye Hospital Co. Ltd from April 2022 to March 2024. The interval between primary and secondary surgery was 77.25±67.19 days (1-186 d). Patients undergoing secondary surgery for vault abnormalities were divided into the high- (17 cases,18 eyes) and low-vault (14 cases,15 eyes) groups. Thirty eyes from 30 patients who underwent simple ICL/TICL implantation served as the control group. The following anterior segment parameters were compared among the groups at initial preoperative assessment:spherical equivalent (SE),horizontal white-to-white corneal diameter (hWTW),horizontal sulcus-to-sulcus diameter (hSTS),anterior chamber depth (ACD),anterior chamber volume (ACV),anterior chamber angle (ACA),and lens thickness (LT). The efficacy and safety of secondary surgery were analyzed based on assessments of the postoperative uncorrected visual acuity (UCVA),SE,intraocular pressure (IOP),corneal endothelial cell density (ECD),and complications at 1 month after surgery. Results Among the 37 eyes (35 patients) while underwent secondary surgery,18 required repositioning and 19 required lens exchange (ICL,14 repositioned and 14 exchanged; TICL,4 repositioned and 5 exchanged). Of the 4 TICL eyes that were repositioned,3 were due to residual postoperative astigmatism and 1 was due to haptic displacement into the anterior chamber caused by postoperative ocular trauma. There were no statistically significant differences in preoperative SE,ACA,hWTW,vertical sulcus-to-sulcus diameter (vSTS),or axial length (AL) among the high-arch-height,low-arch-height (at initial surgery),and control groups (P > 0.05). However,the differences in ACD,ACV,hSTS,hWTW-hSTS,and LT were statistically significant (P < 0.05). Intergroup comparisons revealed that ACD and ACV were significantly lower in the low-vault group compared with high-vault and control groups (P < 0.05),while LT was significantly higher in the low-vault group than in the other two groups (P < 0.05). The hSTS in the low-vault group were significantly lower than that in the control group (P < 0.05),while the hWTW-hSTS was significantly higher than that in the control group (P < 0.05). In patients who underwent TICL with residual astigmatism due to intraocular lens rotation,astigmatism decreased to -0.75 D±0.25 D at 1 month after repositioning,while UCVA (LogMAR) improved from 0.18±0.15 to -0.13±0.05; these differences in astigmatism and UCVA before and after surgery were statistically significant (P < 0.001).Compared with the control group,patients who underwent secondary surgery showed no statistically significant differences in UCVA,SE,IOP,and ECD at 1 month after surgery (P > 0.05). Conclusion Vault abnormalities and residual astigmatism are the primary indications for secondary surgery after ICL implantation. Secondary surgery is both safe and effective; however,there remains room for further optimization of ICL size selection.
| [1] |
Castro-Luna G,Jiménez-Rodríguez D,Pérez-Rueda A, |
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
杨治坤,罗岩. ICL植入术后早期非计划再次手术临床分析 [J]. 中华眼视光学与视觉科学杂志,2022,24 (10):746-751. DOI:10.3760/cma.j.cn115909-20211227-00504. |
| [6] |
|
| [7] |
中华医学会眼科学分会眼视光学组. 中国有晶状体眼后房型人工晶状体植入术专家共识 (2019年) [J]. 中华眼科杂志,2019,55 (9):652-657. DOI:10.3760/cma.j.issn.0412-4081.2019.09.005. |
| [8] |
|
| [9] |
杨云,刘亚东. 中央孔型ICL V4c植入术矫正中高度近视的稳定性及高阶像差分析 [J]. 国际眼科杂志,2019,19 (4):644-648. DOI:10.3980/j.issn.1672-5123.2019.4.26. |
| [10] |
|
| [11] |
李帅飞,游昌涛,陈东栋, |
| [12] |
Guber I,Mouvet V,Bergin C, |
| [13] |
|
| [14] |
|
| [15] |
Zaldivar R,Zaldivar R,Adamek P, |
| [16] |
|
| [17] |
余鹏,黄亮,李青. 眼部参数预测有晶状体眼后房型人工晶状体植入术后拱高异常的研究 [J]. 中华眼科杂志,2023,59 (12):1003-1011. DOI:10.3760/cma.j.cn112142-20231024-00167. |
| [18] |
|
| [19] |
王静,沙玛丽·哈力木别克,陈利群, |
| [20] |
郑两定,肖晓婷,陈雅丽. 基于UBM相关数据优化有晶状体眼后房型人工晶状体选择对术后拱高的影响 [J]. 国际眼科杂志,2025,25 (3):469-474. DOI:10.3980/j.issn.1672-5123.2025.3.24 |
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
熊洁,张辰星,罗启惠, |
| [27] |
王红霞,周奇志. 有晶状体眼后房型人工晶状体植入术后人工晶状体更换手术的短期临床效果 [J]. 中华眼视光学与视觉科学杂志,2018,20 (7):437-441. DOI:10.3760/cma.j.issn.1674-845X.2018.07.009. |
| [28] |
谢秀丽. ICL晶状体更换手术的有效性与安全性探讨 [J]. 国际眼科杂志,2013,13 (5):939-940. DOI:10.3980/j.issn.1672-5123.2013.05.29. |
/
| 〈 |
|
〉 |